https://www.businesswire.com/news/home/20230213005251/en/LegoChemBio-Signs-License-Agreement-to-Acquire-First-in-class-Antibody-From-Elthera
Rütistrasse 16, 8952 Schlieren, Schweiz
InkVivo Technologies combines its patented biomaterial platform with advanced manufacturing technologies to fabricated novel delivery systems that ensure controlled and prolonged release of active ingredients (e.g., small molecules, biologics and micronutrients).
Provectis Healthcare AG is a global healthcare company based in Basel and the commercial partner of choice to the innovative biopharma. We advance the innovation through launch, commercialization and brand building in Europe, Middle East and Asia.
Tenpoint is a biotechnology company committed to advancing engineered cell-based therapies and in vivo reprogramming to restore vision for people with degenerative ocular diseases, bringing together the global experts shaping the regenerative ocular medicine revolution.